Filing Details

Accession Number:
0001209191-23-007769
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-08 16:04:15
Reporting Period:
2023-02-06
Accepted Time:
2023-02-08 16:04:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831828 Vera Therapeutics Inc. VERA Pharmaceutical Preparations (2834) 812744449
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1872792 Sean Grant C/O Vera Therapeutics, Inc.
8000 Marina Boulevard, Suite 120
Brisbane CA 94005
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-02-06 14,285 $7.00 49,933 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 2,816 Indirect By IRA
Class A Common Stock 335 Indirect By Roth IRA
Class A Common Stock 857 Indirect By Spouse's IRA
Class A Common Stock 992 Indirect By Trust
Footnotes
  1. Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023. The purchase price is the offering price.
  2. Includes 380 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022.